The dawn of
individualized care is here.
We’re revolutionizing health management by combining AI with the world's most comprehensive biological data. Our advanced insights empower individuals and healthcare providers to predict, prevent, diagnose, manage, and treat a wide range of health conditions.
Our Mission
Harnessing the power of AI and the world’s most comprehensive biological data, we are providing individuals and their physicians with a holistic, granular, and high-fidelity representation of their individual health state and options for improvement.
What We’re Working On
Aurora Discovery
The Aurora Discovery Study is the forefront of personalized health research.
This pioneering initiative captures a longitudinal and integrated view of health by simultaneously analyzing a wide array of biological markers and their interrelationships.
This study is exploratory—it’s the first of its kind to apply such a comprehensive suite of biological analyses to consumer health research. Our findings aim to push the boundaries of what is known about health and disease, with the potential to offer significant insights.
Our Founders
Jamie Heywood
CEO & Co-founder
Jamie is an MIT-trained mechanical engineer who entered biomedicine after his brother was diagnosed with ALS in 1999.
Prior to Alden Scientific, Jamie founded the ALS Therapy Development Institute, PatientsLikeMe, and AOBiome, and co-founded Genetic Networks, The SocialMedwork, and iCarbonX International.
His focus has been on addressing fundamental improvements in the discovery and development of treatments and management of health and disease and in empowering individuals. Jamie’s work has been profiled in The New Yorker, 60 Minutes, TEDMED, Pulitzer Prize winner Jonathan Wiener’s book, His Brother’s Keeper, and the Sundance award-winning documentary So Much So Fast.
Jeff Cole
COO & Co-founder
Jeff has over 25 years of experience as a technology and management leader in diverse areas including preclinical research, digital health, manufacturing and consumer and business platforms. He brings bioinformatics experience from his work architecting the platform at PatientsLikeMe, as well as building informatics systems for the ALS Therapy Development Institute.
Jeff has co-founded 3 companies- PatientsLikeMe, Input Factory (which was acquired by Google), and now Alden Scientific.
Jeff earned his BS and MS at MIT in Mechanical Engineering with a focus in systems dynamics.